Back

Effect of PCSK9 inhibitors treatment on acute coronary syndrome and stroke incidence: a metanalysis of currently available clinical trials

3 September 2019 (11:54 - 12:12)
Organised by:
Congress Presentation Part of: Lipid modification for the 21st century Drug therapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Alberto Cordero

General University Hospital Doctor Balmis of Alicante, Alicante (Spain)

4 More presentations in this session

Presentation thumbnail
State of the Art - The symphony of lipids in 2019
Professor U. Laufs (Leipzig, DE)
Slides Video
Presentation thumbnail
Association between degree of LDL-cholesterol decrease after a myocardial infarction and mortality - a nationwide cohort study
Doctor J. Schubert (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Unmet need for secondary prevention in individuals from the general population with increased lipoprotein(a): a contemporary population-based study
Doctor C. Madsen (Herlev, DK)
Abstract
Presentation thumbnail
Novel biomarkers in the lipid area.
Professor B. Nordestgaard (Copenhagen, DK)
Slides Video

Access the full session

Session thumbnail
Lipid modification for the 21st century

The Event

Event poster

ESC Congress 2019

3 September 2019 11:54 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of proprotein covertase subtilisin/kexin type 9 inhibitors among patients with acute coronary syndrome: a meta-analysis of randomized controlled trials
27 August 2022
thumbnail
Congress Presentation
Statins for venous thromboembolism prevention: old dog, new tricks
1 September 2020
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials
27 August 2021
thumbnail
Congress Session
Novel pharmacological approaches in acute coronary syndromes
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources